Subscribe To
ACSB / Acesis Holdings Proposes Terms For U.S. Micro-IPO
Acesis Holdings Corporation has filed for an IPO to raise $6.5 million in funding. The biopharma company is developing treatments for low testosterone conditions in males. Acesis has low financial resources and is at an ultra-early stage of pipeline development, making the IPO high-risk.
Read More
Posted: Sep 18 2023, 12:53
Author Name: Seeking Alpha
Views: 041364
ACSB News
By Seeking Alpha
September 18, 2023
Acesis Holdings Proposes Terms For U.S. Micro-IPO
Acesis Holdings Corporation has filed for an IPO to raise $6.5 million in funding. The biopharma company is developing treatments for low testosterone more_horizontal